| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/2006 | CN1264512C Pharmaceutical compositions containing aminothiazole derivatives for treatment of colonic motion dysfunctions |
| 07/19/2006 | CN1264511C Preparation and use of extracting protopine from plant |
| 07/19/2006 | CN1264510C Application of geldanamycin (C-3559) preparation of medicine for curing condyloma acuminatum |
| 07/19/2006 | CN1264509C Precursor liposome preparation containing silybum marianum extract and its preparing process |
| 07/19/2006 | CN1264508C Arteannuin preparation for treating gynecopathy |
| 07/19/2006 | CN1264507C Application of skullcap root extract in preparing medicine for nasopharyngeal carcinoma |
| 07/19/2006 | CN1264506C preparation method of pharmaceutical combination containing red sage root element |
| 07/19/2006 | CN1264505C Freeze dry powder injection of ketoprofen |
| 07/19/2006 | CN1264502C Injection of still-freeze drying powder for restoring consciousness and new preparation method |
| 07/19/2006 | CN1264500C Fat milk transfusion fluid for treating pulmonary heart disease and energy supplement and its producing method |
| 07/19/2006 | CN1264499C Cosmtics treatment using novel retinoid |
| 07/19/2006 | CN1264430C Nucleotide and amino acid nutrient products and their production |
| 07/19/2006 | CN1264414C Compound immunopotentiator for prawn breeding |
| 07/18/2006 | USRE39199 Antipsoriatic compositions, method of making, and method of using |
| 07/18/2006 | USRE39198 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078566 Organic acid salts for treating tumor diseases, autoimmune diseases, cardiovascular diseases, infections, and viral diseases; nonsettling by inorganic phosphates, nontoxic to tissue, inhibition of sphingomyelinase |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078558 Salt formated crystal for treating hypercholesterolemia and hyperlipidemia; anticholesterol agents, antilipemic agents |
| 07/18/2006 | US7078542 pi-electron donor group bonded to a pi-electron conjugated bridge group bonded to a mono- or dicyanodihydrofuran acceptor; large hyperpolarizability, dipole moment, and electrooptic coefficients; electrooptics |
| 07/18/2006 | US7078541 Antiinflammatory agents; antiischemic agents; central nervous system disorders; prevent tissue degradation |
| 07/18/2006 | US7078538 novel intermediates useful in the synthesis of 14 beta -hydroxy-1,14-carbonate-deacetylbaccatin III derivatives; 7,10-bistrichloroacetyl-10-deacetylbaccatin III; 13-dehydro-14 beta -hydroxy-7-triethylsilylbaccatin III; 13-dehydro-14 beta -hydroxy-7,10-bistrichloroacetyl-baccatin III 1,14-carbonate |
| 07/18/2006 | US7078537 Phenylalkyl diamine and amide analogs |
| 07/18/2006 | US7078536 Antiproliferative agents; for prevention of infections; for veterinary medicine, agriculture |
| 07/18/2006 | US7078534 Activation the corresponding keto ester; reacting with cysteamine; hydrogenation; crystallization in solvent |
| 07/18/2006 | US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 07/18/2006 | US7078523 Viricides; anticancer agents; immunology moderators |
| 07/18/2006 | US7078522 2-heterocycle-7-oxo-pyrido-[2,3-d]-pyrimidines or 2-oxo-7-heterocycle-1,6-naphthyridines; phosphodiesterase V inhibitors; erectile dysfunction; side effect reduction |
| 07/18/2006 | US7078521 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound |
| 07/18/2006 | US7078518 Forms of 5-Azacytidine |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078506 Canineil-4nucleic acid molecules and uses thereof |
| 07/18/2006 | US7078438 N-(4 substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/18/2006 | US7078437 suppressing degradation of apolipoprotein D to prevent schizophrenia or other diseases caused by denaturation or cell damage in the nervous system, such as Alzheimer's disease, Niemann-Pick disease type C and Unverrichit-Lundborg disease by administering lauric acid or oleic acid |
| 07/18/2006 | US7078436 Administering halosubstitured phenyl alkyl carbamate compound for therapy of anxiety |
| 07/18/2006 | US7078435 Autoinducer compounds |
| 07/18/2006 | US7078434 inhibiting the proliferation of breast cancer cells characterized by increased expression of peripheral-type benzodiazepine receptor protein by determining whether the cells exhibit an at least 3-fold increase of the protein and administering isolated Ginkgolide B |
| 07/18/2006 | US7078433 FC101 and analogs as a method of treatment for cancer |
| 07/18/2006 | US7078432 Process for the preparation of the 14β-hydroxy-baccatin III-1,14-carbonate |
| 07/18/2006 | US7078431 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders |
| 07/18/2006 | US7078430 3-carbamoyl-pyran that is n-derivatized by dihydroxyheptanoic acid or 6-ethyl-4-hydroxy-pyran-2-one; anticholesterol agents |
| 07/18/2006 | US7078429 Substituted 3-carbonyl-1H-indol-1-yl acetic acid derivatives for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis; Alzheimer's disease |
| 07/18/2006 | US7078428 3-(Guanidinylcarbonylmethyl)-substituted; inhibit the cellular sodium-proton antiporter, in particular NHE1; antiarrhythmic agents;cardioprotective for infarction prophylaxis and treatment; preventing ischemia-induced damage |
| 07/18/2006 | US7078427 Bioavailability; anticancer agents; viricides |
| 07/18/2006 | US7078426 Central nervous system disorders |
| 07/18/2006 | US7078425 4-(2-substituted aminocarbonyl-2-substituted aminoethyl)-7-carboxymethoxy- indole, indazole, indoline, benzotriazole or benzoimidazole derivatives, e.g., 4-[2-Benzenesulfonylamino-2-(4-phenyl-butylcarbamoyl)-ethyl]-1H-indazol-7-yloxy}-acetic acid; treating or preventing Type II Diabetes Mellitus |
| 07/18/2006 | US7078424 Central nervous system disorders; alopecia |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078419 Cytokine inhibitors |
| 07/18/2006 | US7078418 e.g., 2,6-bis(1-aziridino-1-hydroxyiminomethyl)pyridine; treating colon, stomach, lung, breast and uterus cancer |
| 07/18/2006 | US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078415 1-(omego-substituted-2-[(hetero)arylcarbonylamino]alkanoyl)-4-(1-methylpiperidin-4-yl)piperidine derivatives; e.g., 1-[N-(Indole-6-carbonyl)-D-serinyl]-4-(1-methylpiperidin-4-yl)piperidine Hydrochloride |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078412 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2] octane in salt form, particularly bromide or trifluoroacetate, for treatment of respiratory disorders, alone or in combination with other bronchodilatory compounds |
| 07/18/2006 | US7078411 Phospholipid transfer protein (PLTP) and cholestoral metabolism |
| 07/18/2006 | US7078410 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 07/18/2006 | US7078409 Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| 07/18/2006 | US7078408 administering pyrimidinotriazole derivatives for improving motor impairment due to Parkinson's Disease |
| 07/18/2006 | US7078407 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them |
| 07/18/2006 | US7078406 using derivatives of 2-(4'-sulfamoylphenyl)-5-(4'-dimethylaminophenyl)oxazoles to monitor a cell environment; improved utility in thermal shift bioassays |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078404 Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078402 Sulfur compounds such as S-methyl 4-dimethylamino-4-methyl-2-pentynethioate, used for prophylaxis of cancers, skin disorders or vision defects |
| 07/18/2006 | US7078401 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 07/18/2006 | US7078400 20-hydroxyeicosatetraenoic acid (HETE); useful as therapeutic agents for kidney diseases, cerebrovascular diseases, or circulatory diseases |
| 07/18/2006 | US7078399 Antiulcer agents; antiinflammatory agents; therapy for ear infections |
| 07/18/2006 | US7078398 Compositions and methods for treating or preventing convulsions or seizures |
| 07/18/2006 | US7078397 Comprises thiadiazolidinedione-based insulin sensitizers (troglitazone); peroxisome proliferator-activated receptors |
| 07/18/2006 | US7078396 Method of treating disorder related to high cholesterol concentration |
| 07/18/2006 | US7078395 administering hydrocarbyl- or hydrocarbyloxy-substituted oestrones, oestrones, oestradiols, oestradiols, oestriols or oestriols containing a sulfamate group |
| 07/18/2006 | US7078394 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen as above and a progestogen equivalent to 90 mu g per day of norgestimate. |
| 07/18/2006 | US7078393 Method of producing 1-hydroxy-1,1-diphosphonic acid compounds |
| 07/18/2006 | US7078392 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 07/18/2006 | US7078391 Method of treating edematous retinal disorders |
| 07/18/2006 | US7078390 Ribozymes to growth factor originating in human platelet |
| 07/18/2006 | US7078389 Hybridization of a mutagen substituted single-strand nucleic acid molecule with DNA causes a mutation at a specific site; antiproliferative and anticarcinogenic agents; gene therapy |
| 07/18/2006 | US7078386 Enhancing agent for nerve growth factor production comprising a compound having a coumarin backbone or a compound having a 2-dimethyl chroman backbone |
| 07/18/2006 | US7078381 Method of regulating glucose metabolism, and reagents related thereto |
| 07/18/2006 | US7078380 comprises vancomycin-type antibiotics; peptide antibiotics; membrane proteins; defensins; for inhibiting peptidoglycan biosynthesis |
| 07/18/2006 | US7078379 Treatment of congenital muscular dystrophies |
| 07/18/2006 | US7078236 Methods of inducing ovulation |
| 07/18/2006 | US7078223 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture |
| 07/18/2006 | US7078209 Fused nitrogen heterocyclic compounds; treating fungal diseases |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078193 Pathogenic Escherichia coli associated protein espA |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078178 Identifying modulators of transmembrane calcium transfer; for treating bone, cancer and blood disorders |
| 07/18/2006 | US7078064 Antioxidation; reducing oxidative stresses; oral administering of mixture of glycyrrhzin, vitamin c, silymarin, lipoic acid and tocopherol |
| 07/18/2006 | US7078063 Water soluble extract from plant of Solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
| 07/18/2006 | US7078062 Antiseptics; plant extracts in aqueous solution |
| 07/18/2006 | US7078060 Contacting an area with a solution of atomically disordered, nanocrystalline metal, metal alloy or metal compound; drug delivery; microbiocides; bactericides; fungicides; anticarcinogenic, -tumor and -inflammatory agents; viricides |
| 07/18/2006 | US7078059 Treatment of bone diseases |
| 07/18/2006 | US7078058 Corticosteroid-containing pharmaceutical composition |
| 07/18/2006 | US7078057 Heating with carrier; mixtur eof fine and coarse particle sizes |